Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 2
2015 1
2016 2
2017 2
2018 3
2019 3
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Corrigendum to "Gold nanoparticle conjugated Rad6 inhibitor induces cell death in triple negative breast cancer cells by inducing mitochondrial dysfunction and PARP-1 hyperactivation: Synthesis and characterization" [Nanomedicine 12 (3) (2016), 745-757].
Haynes B, Zhang Y, Liu F, Li J, Petit S, Kothayer H, Bao X, Westwell AD, Mao G, Shekhar MP. Haynes B, et al. Among authors: kothayer h. Nanomedicine. 2019 Jun;18:426. doi: 10.1016/j.nano.2019.01.005. Epub 2019 Feb 3. Nanomedicine. 2019. PMID: 30726707 No abstract available.
RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance.
Somasagara RR, Spencer SM, Tripathi K, Clark DW, Mani C, Madeira da Silva L, Scalici J, Kothayer H, Westwell AD, Rocconi RP, Palle K. Somasagara RR, et al. Among authors: kothayer h. Oncogene. 2017 Nov 30;36(48):6680-6690. doi: 10.1038/onc.2017.279. Epub 2017 Aug 14. Oncogene. 2017. PMID: 28806395 Free PMC article.
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page